Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 11 matching records.
11 results — page 1 of 1
- Level CCohort StudyPubMed
Real-life effectiveness of allogeneic expanded adipose-derived mesenchymal stem cell therapy for perianal fistulizing refractory Crohn's disease.
Cohort Study with a reported sample of 36 on Scar, Autoimmune Research, published in Clin Res Hepatol Gastroenterol (2024) — summary generated from the PubMed abstract.
- 2024
- n = 36
Clin Res Hepatol Gastroenterol - Level DNarrative ReviewEurope PMC
Refractory Crohn's Disease: Perspectives, Unmet Needs and Innovations
Narrative Review on Immune Modulation, Autoimmune Research, published in Clin Exp Gastroenterol (2024) — summary generated from the PubMed abstract.
- 2024
Clin Exp Gastroenterol7 citations - Level BClinical TrialEurope PMC
Local fistula injection of allogeneic human amnion epithelial cells is safe and well tolerated in patients with refractory complex perianal Crohn's disease: a phase I open label study with long-term follow up
Clinical Trial with a reported sample of 4 on Autoimmune Research, published in EBioMedicine (2023) — summary generated from the PubMed abstract.
- 2023
- n = 4
EBioMedicine13 citations - Level CRetrospective StudyPubMed
Three-year outcome of local injection of autologous stromal vascular fraction cells and microfat in refractory perianal fistulas of Crohn's disease.
Retrospective Study with a reported sample of 7 on Autoimmune Research, published in Stem Cell Res Ther (2022) — summary generated from the PubMed abstract.
- 2022
- n = 7
Stem Cell Res Ther14 citations - Level CProspective StudyPubMed
Stem Cell Injection for Complex Refractory Perianal Fistulas in Crohn's Disease: A Single Center Initial Experience.
Prospective Study on Chronic Inflammation, Autoimmune Research, published in Front Surg (2022) — summary generated from the PubMed abstract.
- 2022
Front Surg9 citations - Level ASystematic ReviewEurope PMC
Stem cell transplantation for induction of remission in medically refractory Crohn's disease
Systematic Review with a reported sample of 442 on Autoimmune Research, published in Cochrane Database Syst Rev (2022) — summary generated from the PubMed abstract.
- 2022
- n = 442
Cochrane Database Syst Rev11 citations - Level BClinical TrialPubMed
Durable Response in Patients With Refractory Fistulizing Perianal Crohn's Disease Using Autologous Mesenchymal Stem Cells on a Dissolvable Matrix: Results from the Phase I Stem Cell on Matrix Plug Trial.
Clinical Trial with a reported sample of 20 on Autoimmune Research, published in Dis Colon Rectum (2022) — summary generated from the PubMed abstract.
- 2022
- n = 20
Dis Colon Rectum15 citations - Level CProspective StudyPubMed
Stromal vascular fraction with platelet-rich plasma injection during surgery is feasible and safe in treatment-refractory perianal fistulising Crohn's disease: A pilot study.
Prospective Study with a reported sample of 24 on Autoimmune Research, published in Aliment Pharmacol Ther (2022) — summary generated from the PubMed abstract.
- 2022
- n = 24
Aliment Pharmacol Ther9 citations - Level ASystematic ReviewPubMed
TRANSPLANTATION OF ADIPOSE-DERIVED MESENCHYMAL STEM CELLS IN REFRACTORY CROHN'S DISEASE: SYSTEMATIC REVIEW.
Systematic Review on Scar, Autoimmune Research, published in Arq Bras Cir Dig (2019) — summary generated from the PubMed abstract.
- 2019
Arq Bras Cir Dig10 citations - Level CProspective StudyPubMed
Stem Cell Therapy in Refractory Perineal Crohn's Disease: Long-term Follow-up.
Prospective Study on Autoimmune Research, published in Colorectal Dis (2018) — summary generated from the PubMed abstract.
- 2018
Colorectal Dis - Level DNarrative ReviewPubMed
Darvadstrocel: A Review in Treatment-Refractory Complex Perianal Fistulas in Crohn's Disease.
Narrative Review on Autoimmune Research, published in BioDrugs (2018) — summary generated from the PubMed abstract.
- 2018
BioDrugs31 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406